American Journal of Clinical Dermatology

, Volume 7, Issue 6, pp 397–398 | Cite as

Toxic Epidermal Necrolysis in Oncologic Patients

  • Gianpiero Gravante
  • Daniela Delogu
  • Gaetano Esposito
  • Antonio Montone



No sources of funding were used to assist in the preparation of this study. The authors have no conflicts of interest that are directly relevant to the content of this study.


  1. 1.
    Wyatt AJ, Leonard GD, Sachs DL. Cutaneous reactions to chemotherapy and their management. Am J Clin Dermatol 2006; 7 (1): 45-63PubMedCrossRefGoogle Scholar
  2. 2.
    Chia WK, Lim YL, Greaves MW, et al. Toxic epidermal necrolysis in patient with breast cancer receiving letrozole. Lancet Oncol 2006; 7 (2): 184-5PubMedCrossRefGoogle Scholar
  3. 3.
    Vincenzi B, Santini D, Grilli C, et al. Complications of therapy in cancer patients: case 3. Toxic epidermal necrolysis induced by oral phenobarbital and whole-brain radiotherapy in a breast cancer patient. J Clin Oncol2004; 22 (22): 4649-51Google Scholar
  4. 4.
    Aguiar D, Pazo R, Duran I, et al. Toxic epidermal necrolysis in patients receiving anticonvulsants and cranial irradiation: a risk to consider. J Neurooncol 2004; 66 (3): 345-50PubMedCrossRefGoogle Scholar
  5. 5.
    Curigliano G, Formica V, De Pas T, et al. Life-threatening toxic epidermal necrolysis during voriconazole therapy for invasive aspergillosis after chemotherapy. Ann Oncol 2006; 17 (7): 1174-5PubMedCrossRefGoogle Scholar
  6. 6.
    Roujeau JC, Kelly JP, Naldi L, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995; 333 (24): 1600-7PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2006

Authors and Affiliations

  • Gianpiero Gravante
    • 1
  • Daniela Delogu
    • 2
  • Gaetano Esposito
    • 3
  • Antonio Montone
    • 3
  1. 1.University of Rome Tor VergataRomeItaly
  2. 2.University ‘La Sapienza’ of RomeRomeItaly
  3. 3.Burn CenterS. Eugenio HospitalRomeItaly

Personalised recommendations